Philadelphia, PA – According to filings with the U.S. Securities and Exchange Commission, Proscia is raising $22,957,167.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, David West played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Proscia

 Our mission is to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology. We’re building tools for the mind that are redefining pathology and giving pathologists better ways to fight cancer today. We founded Proscia with a vision for what pathology could become. With the support of forward-thinking partners, investors, and laboratories, our vision is rapidly becoming a reality.

To learn more about Proscia, visit http://proscia.com/

Contact:
David West, President and Chief Executive Officer
877-255-1341
david@proscia.com
https://www.linkedin.com/in/david-west-07b07156/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved